Study of Cognixion ONE Augmented Reality Brain-Computer Interface for Communication in Adults with Late Stage ALS

What this Trial Is About

Researchers are evaluating the usability of an augmented reality brain computer interface BCI communication platform for people with late stage ALS Amyotrophic Lateral Sclerosis. The study aims to understand how quickly participants can learn and become confident with a pure BCI interface, how effective alternative inputs like eye tracking are, and how generative AI personalization affects communication quality. Up to 10 participants in the greater Los Angeles area will take part in this study. Each participant will receive a Cognixion Axon-R device, a wearable augmented reality BCI with built-in computer and software designed to support communication. Participants will use the device and its communication software for practice and communication tasks as directed by the study administrator. The study lasts 3 months for each participant, during which they will regularly use the device and software. Participants will be involved in training and using the device, with researchers measuring outcomes such as the System Usability Score and Information Transfer Rate after 3 months of use. Words per Minute will also be tracked as a secondary outcome. The study will monitor how well participants can communicate with the device and assess its ease of use. The total participation time is 3 months from training and setup of the device.

Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS